• Home
  • NEW DAY MEDICINE
  • 3 (41) 2022
  • 56 -3 (41) 2022 — Zokirov V.Z., Yuldosheva D.H. — COMPARATIVE CHARACTERISTICS OF LABORATORY AND BIOCHEMICAL ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN MIDDLE AND ELDERLY PATIENTS WITH COVID-19

56 -3 (41) 2022 — Zokirov V.Z., Yuldosheva D.H. — COMPARATIVE CHARACTERISTICS OF LABORATORY AND BIOCHEMICAL ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN MIDDLE AND ELDERLY PATIENTS WITH COVID-19

COMPARATIVE CHARACTERISTICS OF LABORATORY AND BIOCHEMICAL ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN MIDDLE AND ELDERLY PATIENTS WITH COVID-19

Zokirov V.Z. Bukhara State Medical Institute, Uzbekistan

Yuldosheva D.H. Bukhara State Medical Institute, Uzbekistan

Resume

This article analyzes a special experiment on the parameters of pigment metabolism, cytolysis and cholestasis to assess the functional state of the liver in non-alcoholic fatty liver disease in middle-aged and elderly patients who underwent COVID-19. The study included a control group of patients who did not have COVID-19, an experimental group of patients diagnosed with COVID-19, a history (periodic abstinence from alcoholic beverages) was collected to rule out alcoholic fatty liver disease and isolated using a special CAGE examination. The conclusion was made on the basis of the PCR test COVID-19. Analyzed biochemical tests.

Conclusion: Non-alcoholic fatty liver disease (NAFLD) is an important disease of the gastrointestinal tract. An increase in high biochemical parameters is observed in patients with COVID-19, confirmed by severe liver damage. Our study presented and compared laboratory analyzes of 178 middle-aged and elderly patients with COVID-19.

Key words: COVID-19, non-alcoholic fatty liver disease, biochemical analysis, total bilirubin, total cholesterol, atherogenic index.

First page

271

Last page

274

For citation: Zokirov V.Z., Yuldosheva D.H. COMPARATIVE CHARACTERISTICS OF LABORATORY AND BIOCHEMICAL ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN MIDDLE AND ELDERLY PATIENTS WITH COVID-19 //New Day in Medicine 3(41)2022 271-274 https://clck.ru/g57PX

LIST OF REFERENCES:

  1. Ильченко Л.Ю., Никитин И.Г., Федоров И.Г. COVID-19 и поражение печени. Архивъ внутренней медицины. 2020;10(3):188- 197. https://doi.org/10.20514/2226-6704-2020-10-3-188-197.
  2. Маев И.В., Бордин Д.С. Ведение пациентов с хроническими заболеваниями печени в условиях пандемии COVID-19 // Методические рекомендации // Москва 2020. – стр- 28.
  3. Маннанова И. В., Понежева Ж. Б., Макашова В. В., Омарова Х. Г., Рейзис А. Р.,Горелов А. В. 2020. некоторые аспекты повреждения печени при инфекции, вызванной sars-cov-2. COVID-19 preprints.microbe.ru.https://doi.org/10.21055/preprints-3111776
  4. Пинчук Т. В., Орлова Н. В., Суранова Т. Г., Бонкало Т. И. Механизмы поражения печени при COVID 19. Медицинский алфавит. 2020; (19): 39–46. https://doi.org/10.33667/2078-5631-2020-19-39-46.
  5. Рейзис А.Р., Понежева Ж.Б., Макашова В.В., Омарова Х.Г., Маннанова И.В., Горелов А.В. 2020. Поражение печени при COVID-19. Covid19-preprints.microbe.RU. https://doi.org/10.21055/preprints-3111760
  6. Рейзис А.Р., Понежева Ж.Б., Макашова В.В., Омарова Х.Г., Маннанова И.В., Горелов А.В. 2020. Хронические заболевания печени в период пандемии COVID – 19. Россия.2020. – стр.-1-7.
  7. Тухбатуллин М.Г., Янгуразова А.Е., Галеева З.М. Ультразвуковая эластография сдвиговой волной и лабороторные показатели в диагностике и оценке эффективности лечения неалкогольной жировой болезни печени. //Практическая медицина. 1 (112) март 2018. Стр.-105-111.
  8. Bangash M.N.; Patel J.; Parekh D. COVID-19 and the liver: Little cause for concern. Lancet Gastroenterol. Hepatol. 2020, 5, 529–530. DOI: 10.1016/S 2468–1253(20)30084–4.
  9. Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004; 39: 302–310. DOI: 10.1002/hep.20111.
  10. Хamrayev A.A., Yuldasheva D.H. Clinical, laboratory and molecular-genetic markers of the progression of non-alcoholic fatty liver disease (literature review and own data) // Society and innovations // Special Issue –2 (2021). – P. 399 – 406.
  11. Yuldasheva D.H., Zokirov V.Z., G`ulomova Sh.Q. Non-alcoholic fatty liver disease: Modern view of the problem // A Multidisciplinary Peer Reviewed Journal.Vol.6. Issue 12. Dec.2020. – P. 286 – 292
  12. Yuldasheva D.H. Shadjanova N.S., Oltiboev R.O. Non-alcoholic fatty liver disease and modern medicine // Academicia an international multidisciplinary research journal // Vol.10. Issue 11. Nov.2020. – P. 1931 – 1937.
  13. Yuldasheva D.H., Zokirov V.Z., Oltiboev R.O. Modern approaches to the pathogenesis of non-alcoholic fatty liver disease // Euro-Asia Conferences. – 2021. – P. 384-389.
  14. Yuldasheva D.H., Muxamedova Z.R., Zokirov V.Z. Chronic liver disease and COVID-2019 // E-Conference Globe. – 2021. – P. 193-197.
  15. Zokirov V.Z., Yuldasheva D.H., Muxamedova Z.R., Nasirova Z.J. Аssessment of comparative analysis of the course of non-alcoholic fatty liver disease in middle-aged and elderly patients who suffer covid-19 through ultrasound elastometry (via fibroscan). // World Bulletin of Public Health (WBPH) Available Online. Vol.5. December-2021 – P. 64 – 66
  16. Yuldasheva D.X., Хamrayev A.А. Prevalence of non-alcoholic fatty liver disease, clinical and laboratory markers// Central Asian Journal of Medicine Volume 2022 Issue 2 – P. 112-123
  17. Zokirov V.Z. (2021). Chronic liver disease and covid-2019 (literature review and own data) //Research journal of trauma and disability studies. Vol.1.  December-2021 – P. 1–6.

file

download